Rosetta (ROSG), Complete Genome (GNOM) Shares Surge as Study Finds Genome Sequencing Could Give Early Hints to Disease (GENE)

Stocks in the genome group are on the move Thursday afternoon following a Bloomberg article which cites a recent study as suggesting genome screens on healthy people may offer key hints about their risks of cancer.

The data comes out of the US National Human Genome Research Institute and was released in the American Journal of Human Genetics earlier Thursday. The report specifically mentioned genome sequencing machines from Illumina (Nasdaq: ILMN) and Life Tech (Nasdaq: LIFE), suggesting such devices could be used to alert people to possible risks for disease very early on.

While Illumina and Life Tech shares are relatively calm since the Bloomberg report, shares of Complete Genomics (Nasdaq: GNOM), Rosetta Genomics (Nasdaq: ROSG) and Genetic Technologies (Nasdaq: GENE) are up 7.3 percent, 8.8 percent, and 16.5 percent, respectively.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
• Unilever (UL) shares jump as sales growth accelerate in Q1
• Texas Instruments (TXN) jumps on first above-consensus guide in seven years